Atlas Trials

Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer

Clinical trial NCT07489729 · COMPLETED

Trial details

NCT number
NCT07489729
Sponsor
Tanta University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Hypofractionated DoseProstate Cancer Patients
Start date
2022-06-30
Primary completion
2024-06-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.